Trial · NCT00938314
Outcomes12
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 12 of 12
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | National Institutes of Health Stroke Scale (NIHSS) Change From Baseline at Day 90 | Baseline and Day 90 | The analysis was conducted using a modified Intent-to-Treat population, defined as all randomized patients who received at least one dose of study drug. | scores on a scale | MEAN |
| SECONDARY | NIHSS Response >=4 at Day 90 | Baseline and Day 90 | The analysis was conducted using a modified Intent-to-Treat population, defined as all randomized patients who received at least one dose of study drug. | participants | NUMBER |
| SECONDARY | NIHSS Change From Baseline at Day 30 | Baseline and Day 30 | The analysis was conducted using a modified Intent-to-Treat population, defined as all randomized patients who received at least one dose of study drug. | scores on a scale | MEAN |
| SECONDARY | Modified Rankin Scale (mRS) Response <=2 at Day 90 | Day 90 | The analysis was conducted using a modified Intent-to-Treat population, defined as all randomized patients who received at least one dose of study drug. | participants | NUMBER |
| SECONDARY | Barthel Index at Day 90 | Day 90 | The analysis was conducted using a modified Intent-to-Treat population, defined as all randomized patients who received at least one dose of study drug. | Scores on a scale | MEAN |
| SECONDARY | Action Research Arm Test (ARAT) Change From Baseline at Day 90 | Baseline and Day 90 | Not all patients enrolled in the group completed this outcome measure.~The analysis was conducted using a modified Intent-to-Treat population, defined as all randomized patients who received at least one dose of study drug. | scores on a scale | MEAN |
| SECONDARY | Gait Velocity Test Change From Baseline at Day 90 | Baseline and Day 90 | Not all patients enrolled in the group completed this outcome measure.~The analysis was conducted using a modified Intent-to-Treat population, defined as all randomized patients who received at least one dose of study drug. | seconds | MEAN |
| SECONDARY | Boston Naming Test (BNT) Change From Baseline at Day 90 | Baseline and Day 90 | Not all patients enrolled in the group completed this outcome measure.~The analysis was conducted using a modified Intent-to-Treat population, defined as all randomized patients who received at least one dose of study drug. | Scores on a scale | MEAN |
| SECONDARY | Line Cancellation Test Change From Baseline at Day 90 | Baseline and Day 90 | Not all patients enrolled in the group completed this outcome measure.~The analysis was conducted using a modified Intent-to-Treat population, defined as all randomized patients who received at least one dose of study drug. | scores on a scale | MEAN |
| SECONDARY | Trails A Test Change From Baseline at Day 90 | Baseline and Day 90 | Not all patients enrolled in the group completed this outcome measure.~The analysis was conducted using a modified Intent-to-Treat population, defined as all randomized patients who received at least one dose of study drug. | seconds | MEAN |
| SECONDARY | Trails B Test Change From Baseline at Day 90 | Baseline and Day 90 | Not all patients enrolled in the group completed this outcome measure.~The analysis was conducted using a modified Intent-to-Treat population, defined as all randomized patients who received at least one dose of study drug. | seconds | MEAN |
| SECONDARY | Geriatric Depression Scale at Day 90 | Day 90 | Not all patients enrolled in the group completed this outcome measure.~The analysis was conducted using a modified Intent-to-Treat population, defined as all randomized patients who received at least one dose of study drug. | scores on a scale | MEAN |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00938314/outcomes